Revue des maladies respiratoires最新文献

{"title":"Sommaire","authors":"","doi":"10.1016/S0761-8425(24)00255-9","DOIUrl":"10.1016/S0761-8425(24)00255-9","url":null,"abstract":"","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":null,"pages":null},"PeriodicalIF":0.5,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0761842524002559/pdfft?md5=51140408acf1a7725e38810d2887d70d&pid=1-s2.0-S0761842524002559-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142044739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Lung function during normal pregnancy].","authors":"L Plantier","doi":"10.1016/j.rmr.2024.08.001","DOIUrl":"https://doi.org/10.1016/j.rmr.2024.08.001","url":null,"abstract":"<p><p>Pregnancy is associated with major changes in hormonal status, anatomy and physiology involving all systems of a human organism. This narrative review focuses on the most recent data concerning lung function changes during healthy pregnancy. The major findings are as follows: pregnancy is associated with a reduction in static lung volumes reaching 20% of residual functional capacity; it is also associated with chronic alveolar hyperventilation; lastly, it is not associated with significant changes in variables measured by spirometry such as vital capacity, forced expiratory volume in one second and peak expiratory flow, or airway resistance.</p>","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":null,"pages":null},"PeriodicalIF":0.5,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142056445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Pre-extensively and extensively drug-resistant tuberculosis, in Libreville, Gabon].","authors":"U D Kombila, C Manomba Boulingui, F N'Gomanda, J V Mouity Mavoungou, C B H Ngea Epossi, N Bivigou, S Tsioukaka, J D D Tshisekedi, J Mahoumbou, J B Boguikouma","doi":"10.1016/j.rmr.2024.06.011","DOIUrl":"https://doi.org/10.1016/j.rmr.2024.06.011","url":null,"abstract":"<p><strong>Introduction: </strong>Very few studies have been devoted to extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis (TB) in Gabon.</p><p><strong>Aim: </strong>The aim of the present study is to present the epidemiology of pre-XDR and XDR TB and the evolution over time of patients with multidrug-resistant TB.</p><p><strong>Methods: </strong>This retrospective study covered the activities from 2019 to 2022 of the Nkembo anti-tuberculosis center.</p><p><strong>Results: </strong>Fifteen patients were eligible, including 11 (73.3%) pre-XDR patients and 4 (26.7%) XDR-TB patients. Three (20.0%) patients had HIV/TB co-infection. The sample consisted of 7 men (46.7%) and 8 women (53.3%), a sex ratio (M/F) of 0.87. The average age was 35.6 years, and the median 34 years, with extremes of 23 and 60 years. Eight patients (53.3%) represented new cases of pre-XDR or XDR-TB tuberculosis. The majority (60%; n=9) came from deprived neighborhoods with widespread promiscuity. The therapeutic success rate among pre-XDR patients was 4 (36.4%) versus 2 (50.0%) among XDR-TB patients. Reported mortality occurred 5 (33.3%) patients during treatment, including 3 pre-XDR and 2 XDR-TB patients. In all cases, they died before the end of the first trimester of follow-up.</p><p><strong>Conclusion: </strong>The high frequency of primary pre-extensively drug-resistant tuberculosis underscores the pervasiveness of resistance to anti-tuberculosis drugs and underlines a pressing need for detection of contact cases and early treatment.</p>","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":null,"pages":null},"PeriodicalIF":0.5,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142047146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Changes in mediastinal lymph node sampling practices].","authors":"V Hubaud, H De Lesquen, J-P Avaro","doi":"10.1016/j.rmr.2024.06.012","DOIUrl":"https://doi.org/10.1016/j.rmr.2024.06.012","url":null,"abstract":"<p><strong>Introduction: </strong>While mediastinoscopy is considered the gold standard for mediastinal node sampling, it is to some extent being superseded by endobronchial ultrasound. The objective of this study was to evaluate the different practices in our center regarding mediastinal lymph node sampling in lung cancer patients.</p><p><strong>Methods: </strong>Data were collected from patients having undergone mediastinal lymph node sampling by video-assisted-mediastinoscopy (VM) or by endobronchial ultrasound (EBUS) in our center between August 2020 and July 2023. The modalities of the two procedures and their diagnostic accuracy were analyzed, as was their evolution over time.</p><p><strong>Results: </strong>The 362 patients comprised 217 who were sampled by EBUS and 145 by VM. Overall, the procedures became more frequent, with EBUS tending to supersede VM. The number of harvested lymph nodes gradually grew, and less unforeseen lymph node invasion and upstaging occurred.</p><p><strong>Conclusion: </strong>The arrival in our center of endobronchial ultrasound yielded an overall increase of lymph node sampling despite a decrease in the number of mediastinoscopy procedures performed. Reinforced compliance with guidelines is needed to improve the diagnostic accuracy of these techniques and to better ensure quality of care.</p>","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":null,"pages":null},"PeriodicalIF":0.5,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142047145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Respiratory oscillometry: Theoretical foundations and clinical applications].","authors":"S Bayat","doi":"10.1016/j.rmr.2024.08.002","DOIUrl":"https://doi.org/10.1016/j.rmr.2024.08.002","url":null,"abstract":"<p><p>Oscillometry measures the mechanical properties of the respiratory system. As they are carried out during spontaneous breathing, oscillometry measurements do not require forced breathing maneuvers or the patient's active cooperation. The technique is complementary to conventional pulmonary function testing methods for the investigation of respiratory function, diagnosis and monitoring of respiratory diseases, and assessment of response to treatment. The present review aims to describe the theoretical foundations and practical methodology of oscillometry. It describes the gaps in scientific evidence regarding its clinical utility, and provides examples of current research and clinical applications.</p>","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":null,"pages":null},"PeriodicalIF":0.5,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142036809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[A survey on tobacco-free areas at hospital entrances].","authors":"M Dangles, A Piraud, M Hochet, L T Nguyen","doi":"10.1016/j.rmr.2024.07.008","DOIUrl":"https://doi.org/10.1016/j.rmr.2024.07.008","url":null,"abstract":"<p><strong>Introduction: </strong>In a prevalence and opinion survey on smoking, this work focused on a strategy favoring tobacco-free areas at hospital entrances.</p><p><strong>Methods: </strong>Outreach to the public occupying outdoor spaces led to immediate collection of responses over the course of 13 actions carried out in November 2022, a tobacco-free month.</p><p><strong>Results: </strong>Thirty-two percent of the persons interrogated were smokers, 38% among patients, 26% among professionals and 18% among nursing students. A majority expressed support for smoke-free building entrances, which were viewed by half of the smokers as an encouragement to quit or cut down on their consumption. However, a quarter of participants anticipated difficulties, particularly the \"heaviest\" smokers. In the psychiatry sector, 54% were smokers, and they were relatively unfavorable to the initiative. As for non-smokers, most voiced discomfort regarding the smell of tobacco, the infiltration of smoke in indoor spaces, passive smoking, a negative image of the hospital, and the detrimental ecological impact.</p><p><strong>Conclusions: </strong>The tobacco-free hospital entrance initiative is relevant and of benefit to hospitals. In order to succeed, it must involve all stakeholders, whether they are users or professionals, in a concerted attempt to optimize assistance to smokers wishing to quit, by applying an educational and synergistic approach at all levels.</p>","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":null,"pages":null},"PeriodicalIF":0.5,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142009286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Les reconnaissances en maladie professionnelle lors du suivi de la cohorte ARDCO","authors":"","doi":"10.1016/j.rmr.2024.06.010","DOIUrl":"10.1016/j.rmr.2024.06.010","url":null,"abstract":"<div><h3>Introduction</h3><p>La question de la sous-déclaration des maladies professionnelles (MP) liées à une exposition à l’amiante est régulièrement posée en France. Le suivi de la cohorte multicentrique française de surveillance médicale de sujets ayant été exposés à l’amiante (ARDCO), permet entre autres de connaître les démarches médico-légales entreprises, d’une part, suite au dépistage de pathologies thoraciques bénignes après tomodensitométrie (TDM), et d’autre part, de reconnaissance en MP de pathologies malignes.</p></div><div><h3>Méthodes</h3><p>Les reconnaissances de MP ont été analysées en juillet 2021 parmi 13 289 sujets volontaires de la cohorte recrutée entre 2003 et 2005.</p></div><div><h3>Résultats</h3><p>Quinze pour cent des sujets inclus dans la cohorte avaient au moins une reconnaissance en MP liée à l’amiante (78,2 % de pathologie pleurale bénigne, 10,3 % d’asbestose, 14,2 % de cancer bronchique et 6,0 % de mésothéliome). Seules 58 % des plaques pleurales signalées par le radiologue ayant réalisé la TDM ont donné lieu à une reconnaissance en MP. Parallèlement, 88,7 % des mésothéliomes identifiés à partir des bases de la sécurité sociale et 46,9 % des cancers du poumon ont été reconnus en MP.</p></div><div><h3>Conclusions</h3><p>Cette étude confirme la faisabilité de la mise en place d’un dispositif facilitant la reconnaissance des MP liées à l’amiante. Celle-ci pourrait être améliorée par une meilleure formation des acteurs médicaux impliqués.</p></div><div><h3>Introduction</h3><p>Questions concerning under-reporting of occupational diseases (OD) linked to asbestos exposure are regularly voiced in France. Monitoring of the French multicenter Asbestos-Related Disease Cohort (ARDCO), which ensures post-occupational medical surveillance of subjects having been exposed to asbestos, provides information on (1) the medico-legal steps taken following screening by computed tomography (CT) for benign thoracic diseases, and (2) recognition of OD as a causal factor in malignant diseases.</p></div><div><h3>Methods</h3><p>OD recognition – and possible compensation – was analyzed in July 2021 among 13,289 volunteers in the cohort recruited between 2003 and 2005.</p></div><div><h3>Results</h3><p>Fifteen percent of the subjects in the cohort were found to have at least one recognized asbestos-related OD (78.2% benign pleural disease, 10.3% asbestosis, 14.2% lung cancer, and 6.0% mesothelioma). Only 58% of pleural plaques reported by the radiologist who performed the CT resulted in their recognition as ODs. On a parallel track, 88.7% of the mesotheliomas identified based on French National health insurance data and 46.9% of lung cancers were recognized as ODs.</p></div><div><h3>Conclusions</h3><p>This study confirms the feasibility of a system designed to facilitate recognition, leading to possible compensation, of asbestos-related occupational diseases. The system could be improved by better training of the medical actors involved.</p></di","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":null,"pages":null},"PeriodicalIF":0.5,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141767219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Low-dose methotrexate: Indications and side effects, particularly in cases of diffuse interstitial pneumonia].","authors":"M David, P Dieude, M P Debray, P Le Guen, B Crestani, R Borie","doi":"10.1016/j.rmr.2024.06.008","DOIUrl":"https://doi.org/10.1016/j.rmr.2024.06.008","url":null,"abstract":"<p><strong>Introduction: </strong>Methotrexate (MTX) is a folate antagonist used as an immunosuppressant in a number of conditions, including rheumatoid arthritis (RA). Low-dose MTX (MTX-LD) is associated with a risk of haematological, hepatic, gastrointestinal and pulmonary toxicity, which may up until now have limited its use.</p><p><strong>State of the art: </strong>In RA, data from retrospective cohorts have reported a possible excess risk of methotrexate toxicity in cases of underlying interstitial lung disease (ILD). However, recent prospective and retrospective multicentre studies have found no such increased risk, and have reassuringly concluded that MTX-LD can be prescribed in cases of RA-associated ILD (RA-ILD).</p><p><strong>Perspectives and conclusions: </strong>Current recommendations are not to delay the introduction of MTX in patients with RA at risk of developing ILD or in the presence of RA-ILD with mild to moderate respiratory impairment.</p>","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":null,"pages":null},"PeriodicalIF":0.5,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141724369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recommandations pour la prise en charge de l’encombrement des voies aériennes par les techniques de désencombrement","authors":"","doi":"10.1016/j.rmr.2024.06.001","DOIUrl":"10.1016/j.rmr.2024.06.001","url":null,"abstract":"","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":null,"pages":null},"PeriodicalIF":0.5,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0761842524002250/pdfft?md5=86228dd540ec21ec937d43786269884f&pid=1-s2.0-S0761842524002250-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141724368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Proposals from a French expert panel for respiratory care in ALS patients].","authors":"M Georges, T Perez, C Rabec, L Jacquin, A Finet-Monnier, C Ramos, M Patout, V Attali, M Amador, J Gonzalez-Bermejo, F Salachas, C Morelot-Panzini","doi":"10.1016/j.rmr.2024.06.006","DOIUrl":"https://doi.org/10.1016/j.rmr.2024.06.006","url":null,"abstract":"<p><strong>Background: </strong>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive diaphragm weakness and deteriorating lung function. Bulbar involvement and cough weakness contribute to respiratory morbidity and mortality. ALS-related respiratory failure significantly affects quality of life and is the leading cause of death. Non-invasive ventilation (NIV), which is the main recognized treatment for alleviating the symptoms of respiratory failure, prolongs survival and improves quality of life. However, the optimal timing for the initiation of NIV is still a matter of debate. NIV is a complex intervention. Multiple factors influence the efficacy of NIV and patient adherence. The aim of this work was to develop practical evidence-based advices to standardize the respiratory care of ALS patients in French tertiary care centres.</p><p><strong>Methods: </strong>For each proposal, a French expert panel systematically searched an indexed bibliography and prepared a written literature review that was then shared and discussed. A combined draft was prepared by the chairman for further discussion. All of the proposals were unanimously approved by the expert panel.</p><p><strong>Results: </strong>The French expert panel updated the criteria for initiating NIV in ALS patients. The most recent criteria were established in 2005. Practical advice for NIV initiation were included and the value of each tool available for NIV monitoring was reviewed. A strategy to optimize NIV parameters was suggested. Revisions were also suggested for the use of mechanically assisted cough devices in ALS patients.</p><p><strong>Conclusion: </strong>Our French expert panel proposes an evidence-based review to update the respiratory care recommendations for ALS patients in daily practice.</p>","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":null,"pages":null},"PeriodicalIF":0.5,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141634435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}